The Evaluation and Comparing of Cytotoxic Effects of Ferula gummosa Gum, Scutellaria lindbergii, Kelussia odoratissima and Artemisia kopetdaghensis Extracts on ACHN Cell Line
- PMID: 29201097
- PMCID: PMC5610764
The Evaluation and Comparing of Cytotoxic Effects of Ferula gummosa Gum, Scutellaria lindbergii, Kelussia odoratissima and Artemisia kopetdaghensis Extracts on ACHN Cell Line
Abstract
Renal cell carcinoma (RCC) is one of most fatal cancers. In most patients it is resistant to chemotherapy. Ferula gummosa gum, Scutellaria lindbergii, Kelussia odoratissima, and Artemisia kopetdaghensis are herbs about which there are some cytotoxic activity reports. In this study, cytotoxic and apoptotic activity of these four extracts on RCC cell line (ACHN) were evaluated and compared (ACHN) cells were treated with different concentrations of herbal extracts (15-500 μg/mL). Cell proliferation was determined after 24, 48, and 72 h. by MTT assay. Apoptotic cells were determined using PI staining of DNA fragmentation by flow cytometry. Cell viability decreased with all herbal extracts in ACHN cells by 24, 48, and 72 h. as compared with control. Extracts induced a sub-G1 peak in flow cytometry histogram of treated cells indicating apoptotic cell death is involved in extracts induced-toxicity. Results imply that four herbal extracts inhibit the growth of ACHN cells as a concentration- and time-dependent manner. Also, results show that apoptosis is proposed as the possible mechanism of action. So, four herbal extracts could be considered as good anticancer agents in RCC after further studies.
Keywords: Apoptosis; Artemisia kopetdaghensis; Cytotoxicity; Ferula gummosa gum; Kelussia odoratissima; Scutellaria lindbergii.
Figures





Similar articles
-
Kelussia odoratissima potentiates cytotoxic effects of radiation in HeLa cancer cell line.Avicenna J Phytomed. 2017 Mar-Apr;7(2):137-144. Avicenna J Phytomed. 2017. PMID: 28348969 Free PMC article.
-
Growth-inhibitory effect of Scutellaria lindbergii in human cancer cell lines.Food Chem Toxicol. 2010 Feb;48(2):599-604. doi: 10.1016/j.fct.2009.11.038. Epub 2009 Nov 22. Food Chem Toxicol. 2010. PMID: 19932732
-
Ferula gummosa gum induces apoptosis via ROS mechanism in human leukemic cells.Cell Mol Biol (Noisy-le-grand). 2017 Nov 30;63(11):17-22. doi: 10.14715/cmb/2017.63.11.4. Cell Mol Biol (Noisy-le-grand). 2017. PMID: 29208170
-
Ferula gummosa gum exerts cytotoxic effects against human malignant glioblastoma multiforme in vitro.Res Pharm Sci. 2022 Sep 8;17(5):585-593. doi: 10.4103/1735-5362.355215. eCollection 2022 Oct. Res Pharm Sci. 2022. PMID: 36386486 Free PMC article.
-
Ferula gummosa, a Traditional Medicine with Novel Applications.J Diet Suppl. 2016 Nov;13(6):700-18. doi: 10.3109/19390211.2016.1157715. Epub 2016 Apr 14. J Diet Suppl. 2016. PMID: 27077815 Review.
Cited by
-
Antioxidant, cytotoxic, and genotoxic potentials of the gum of Ferula gummosa Boiss on PC-3 cells.Avicenna J Phytomed. 2023 May-Jun;13(3):316-327. doi: 10.22038/AJP.2022.21605. Avicenna J Phytomed. 2023. PMID: 37655001 Free PMC article.
-
Cytotoxic and apoptotic effects of Ferula gummosa Boiss: extract on human breast adenocarcinoma cell line.Mol Biol Rep. 2024 Apr 29;51(1):592. doi: 10.1007/s11033-024-09364-1. Mol Biol Rep. 2024. PMID: 38683376
-
Plant Gel-Mediated Synthesis of Gold-Coated Nanoceria Using Ferula gummosa: Characterization and Estimation of Its Cellular Toxicity toward Breast Cancer Cell Lines.J Funct Biomater. 2023 Jun 21;14(7):332. doi: 10.3390/jfb14070332. J Funct Biomater. 2023. PMID: 37504827 Free PMC article.
References
-
- Chae EJ, Kim JK, Kim SH, Bae SJ, Cho KS. Renal cell carcinoma: analysis of post-operative recurrence patterns. Radiol. . 2005;234:189–96. - PubMed
-
- Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N. Engl. J. Med. . 1996;335:865–75. - PubMed
-
- Vogelzang NJ, Lipton A, Figlin RA. Subcutaneous interleukin-2 plus interferon alfa-2a in metastatic renal cancer: an outpatient multicenter trial. J. Clin. Oncol. . 1993;11:1809–16. - PubMed
-
- Minasian LM, Motzer RJ, Gluck L, Mazumdar M, Vlamis V, Krown SE. Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up. J. Clin. Oncol. . 1993;11:1368–75. - PubMed
-
- Motzer RJ, Schwartz L, Law TM, Murphy BA, Hoffman AD, Albino AP, Vlamis V, Nanus DM. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interaction in vitro. J. Clin. Oncol. . 1995;13:1950–57. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous